Experienced in Mixed Connective Tissue Disease

Dr. Fotios Koumpouras

Rheumatology
Yale University
20 York St, 
New Haven, CT 
Offers Telehealth
Experienced in Mixed Connective Tissue Disease
Yale University
20 York St, 
New Haven, CT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Fotios Koumpouras is a Rheumatologist in New Haven, Connecticut. Dr. Koumpouras is rated as an Experienced provider by MediFind in the treatment of Mixed Connective Tissue Disease. His top areas of expertise are Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus (DLE), Cutaneous Lupus Erythematosus (CLE), and Lupus Nephritis.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in CT
Hospital Affiliations
Yale-New Haven Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

YALE UNIVERSITY
20 York St, New Haven, CT 06510
Other Locations
YALE UNIVERSITY
5 S Main St, Suite 511, Branford, CT 06405
YALE UNIVERSITY
800 Howard Ave, New Haven, CT 06519
YALE UNIVERSITY
330 Orchard St, New Haven, CT 06511
YALE UNIVERSITY
6 Devine St, North Haven, CT 06473

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Other, Biological
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 18, 2022
Intervention Type: Drug
Study Drug: JBT-101
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
Enrollment Status: Terminated
Publish Date: April 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

20 Total Publications

Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial.
Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial.
Journal: medRxiv : the preprint server for health sciences
Published: April 08, 2025
Similar Doctors
Distinguished in Mixed Connective Tissue Disease
Dr. Helena C. Nolasco
Rheumatology
Distinguished in Mixed Connective Tissue Disease
Dr. Helena C. Nolasco
Rheumatology

Starling Physicians, PLLC

100 Simsbury Rd, 
Avon, CT 
 (35.8 miles away)
860-258-3480
Languages Spoken:
English
See accepted insurances

Helena Nolasco is a Rheumatologist in Avon, Connecticut. Dr. Nolasco is rated as a Distinguished provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Sjogren Syndrome, Mixed Connective Tissue Disease, MASS Phenotype, and Undifferentiated Connective Tissue Disease (UCTD).

Advanced in Mixed Connective Tissue Disease
Dr. Mirela Nicolescu
Rheumatology
Advanced in Mixed Connective Tissue Disease
Dr. Mirela Nicolescu
Rheumatology

Trinity Health Of New England Provider Network Organization Inc

56 Franklin St, 
Waterbury, CT 
 (17.7 miles away)
203-709-6000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mirela Nicolescu is a Rheumatologist in Waterbury, Connecticut. Dr. Nicolescu is rated as a Distinguished provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, MASS Phenotype, and Mixed Connective Tissue Disease.

Advanced in Mixed Connective Tissue Disease
Dr. Asha Shrestha
Rheumatology
Advanced in Mixed Connective Tissue Disease
Dr. Asha Shrestha
Rheumatology

Optum Medical Care PC

90 S Bedford Rd, 
Mount Kisco, NY 
 (41.4 miles away)
914-241-1050
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Asha Shrestha is a Rheumatologist in Mount Kisco, New York. Dr. Shrestha is rated as a Distinguished provider by MediFind in the treatment of Mixed Connective Tissue Disease. Her top areas of expertise are Polymyalgia Rheumatica, Rhizomelic Pseudopolyarthritis, Rheumatoid Arthritis (RA), and Psoriatic Arthritis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Koumpouras's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 45 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile